Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation-Reference-Cited by-同舟云学术

Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation

Published:2014-06-20 Issue:10 Volume:63 Page:1023-1036
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

De Keersmaecker Brenda,Fostier Karel,Corthals Jurgen,Wilgenhof Sofie,Heirman Carlo,Aerts Joeri L.,Thielemans Kris,Schots Rik

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-014-1571-6.pdf

Reference50 articles.

1. Schots R (2011) Recent advances in myeloma treatment. Transfus Apheresis Sci 44:223–229

2. Munshi NC, Anderson KC (2013) New strategies in the treatment of multiple myeloma. Clin Cancer Res 19:3337–3344

3. Munshi NC, Anderson KC, Bergsagel PL et al (2011) Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2. Blood 117:4696–4700

4. Brenner H, Gondos A, Pulte D (2008) Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 111:2521–2526

5. Reichardt VL, Okada CY, Liso A et al (1999) Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study. Blood 93:2411–2419

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What happens to regulatory T cells in multiple myeloma;Cell Death Discovery;2023-12-21

2. Early administration of lenalidomide after allogeneic hematopoietic stem cell transplantation suppresses graft‐versus‐host disease by inhibiting T‐cell migration to the gastrointestinal tract;Immunity, Inflammation and Disease;2022-08-29

3. In silico tools and databases for designing cancer immunotherapy;Immunotherapeutics;2022

4. Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices;Journal of Immunology Research;2021-10-11

5. The Impact of Induction Regimes on Immune Responses in Patients with Multiple Myeloma;Cancers;2021-08-13